Edward Scolnick has provided critical insights into the genetic underpinnings of a variety of psychiatric disorders, including bipolar disorder, schizophrenia, and autism.
After retiring as President at Merck Research Laboratories, Edward Scolnick founded the Stanley Center in 2007, two-and-a-half years after moving to the Broad Institute. His goal is to enhance our understanding of serious mental illnesses like bipolar disorder and schizophrenia. Given that our genetic code greatly influences our risk for developing such diseases, he works to unravel the genome and provide insight into underlying biochemical abnormalities.